Lineage Cell Therapeutics, Inc. (TLV: LCTX)

Lineage Cell Therapeutics Market Cap

Lineage Cell Therapeutics has a market cap or net worth of 620.89 million as of November 19, 2024. Its market cap has decreased by -22.70% in one year.

• Market Cap: 620.89M
• Enterprise Value: 503.65M
• Revenue: 32.41M
• Ranking: n/a
• PE Ratio: n/a
• Stock Price: 362.80

Market Cap Chart

Since May 1, 1992, Lineage Cell Therapeutics's market cap has increased from 49.45M to 620.89M, an increase of 1,155.61%. That is a compound annual growth rate of 8.08%.

Market Cap History

Date	Market Cap	% Change
Nov 18, 2024	620.89M	-9.61%
Dec 29, 2023	686.90M	-1.77%
Dec 30, 2022	699.29M	-45.56%
Dec 31, 2021	1.28B	51.35%
Dec 31, 2020	848.66M	84.29%
Dec 31, 2019	460.49M	10.71%